Time restricted feeding for Prediabetes
This trial will test whether time restricted feeding, or eating within an 8-hour window, can improve health outcomes. There will be 2 groups, one that eats within an 8-hour window and one that doesn't, and various health outcomes will be measured. The study will last 3 1/2 months.
- Breast Cancer
- Time-Restricted Feeding
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
What is the ambition of this clinical trial?
"The foremost purpose of this research, which is to be tracked for about 12 weeks over Visit 1 and Visit 2, will explore fluctuations in Advanced Glycation End Products (AGE) as observed through plasma. Secondary objectives consist of assessing the adherence rate with virtual visits to psychologists, measuring compliance with recommendations on eating times between study groups, and observing RAGE gene expression within peripheral blood mononuclear cells."
How many individuals are currently taking part in this research initiative?
"Affirmative. Clinicaltrials.gov confirms that this clinical trial, which was first posted on May 4th 2022, is actively recruiting patients at the present time. Specifically, 44 individuals need to be enrolled from 1 specific site."
Are there still opportunities for volunteers to join this clinical experiment?
"This clinical trial, first published on May 4th 2022, is actively enrolling patients as per information provided by clinicaltrials.gov and was last amended on September 19th 2022."
Are minors within the age range of 25 and below eligible for participation in this research project?
"According to the stated criteria, enrolment into this clinical trial is limited to individuals between 40 and 60 years of age. The same website has 84 studies that are exclusively for minors and 2671 trials open solely for people over 65."
Am I eligible to partake in this investigation?
"This trial is admitting 44 people with impaired glucose tolerance aged between 40 and 60. The prerequisites for enrolment are as follows: An age of at least 40 years old, but no more than 60; Postmenopausal women (no menstrual periods over the preceding 12 months) presenting with pre-diabetes (A1C 5.7-6.4% or fasting blood glucose 100-125 mg/dL); Lab results confirming A1c and/or fasting glucose must have been obtained within 12 months prior to signing consent form, ideally from a lab located on Medical University of South Carolina's campus which can be verified through their electronic"